These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7940809)

  • 1. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
    Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
    Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of captopril in the treatment of erythrocytosis after renal transplantation.
    Suh BY; Suh JD; Kwun KB
    Transplant Proc; 1996 Jun; 28(3):1557-8. PubMed ID: 8658784
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin, interleukin-3, interleukin-11, and GM-CSF in posttransplant erythrocytosis treated with enalapril.
    Hu RH; Lee PH; Lee CJ
    Transplant Proc; 1996 Jun; 28(3):1545-7. PubMed ID: 8658779
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
    Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
    Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
    Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
    Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril: safe and effective therapy for posttransplant erythrocytosis.
    Gaston RS; Julian BA; Barker CV; Diethelm AG; Curtis JJ
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1029-31. PubMed ID: 8442029
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
    Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
    Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beneficial effect of enalapril on erythrocytosis after renal transplantation.
    Conlon PJ; Farrell J; Donohoe J; Walshe JJ
    Transplantation; 1993 Jul; 56(1):217-9. PubMed ID: 8333046
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of post-renal-transplant erythrosis: ACE inhibitors or theophylline?
    Ben Hmida M; Hachicha J; Jarraya F; Kharrat M; Jarraya A
    Transplant Proc; 1995 Oct; 27(5):2720-1. PubMed ID: 7482889
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventive effect of enalapril on erythrocytosis after renal transplantation.
    Rhee SR; Park SK; Kang SK; Kim SH; Cho BH; Kim JH
    Transplant Proc; 1996 Jun; 28(3):1555-6. PubMed ID: 8658783
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
    Hernández E; Morales JM; Andrés A; Ortuño B; Praga M; Alcazar JM; Fernández G; Rodicio JL
    Transplant Proc; 1995 Aug; 27(4):2239-41. PubMed ID: 7652789
    [No Abstract]   [Full Text] [Related]  

  • 12. New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
    Sauron C; Berthoux P; Berthoux F; Alamartine E; Diab N; Broyet C; Hacini J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1032-3. PubMed ID: 8382847
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
    Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
    Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocytosis in renal transplant recipients.
    Hussain Z; Hashmi A; Ather H; Mohsin R; Hussain M; Naqvi A; Rizvi A
    Transplant Proc; 1995 Oct; 27(5):2736. PubMed ID: 7482896
    [No Abstract]   [Full Text] [Related]  

  • 15. Early posttransplant erythrocytosis in renal allograft recipients.
    Prakash J; Singh S; Behur SK; Ghosh B; Sharatchandra LK; Dwivedi US
    J Assoc Physicians India; 2010 Sep; 58():574-6. PubMed ID: 21391381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].
    Duclos J
    Rev Med Chil; 2000 Feb; 128(2):211-2. PubMed ID: 10962891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
    Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
    Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of enalapril in the treatment of erythrocytosis in patients with renal allografts.
    Carvalho MF; Balbi AL; Corrêa LA; Soares VA
    Transplant Proc; 1996 Dec; 28(6):3377. PubMed ID: 8962316
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of posttransplant erythrocytosis with enalapril.
    Javid R; Ghahramani N; Malek-Hosseini SA; Behzadi S; Rais-Jalali GA
    Transplant Proc; 1999 Dec; 31(8):3226. PubMed ID: 10616453
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism.
    Danovitch GM; Jamgotchian NJ; Eggena PH; Paul W; Barrett JD; Wilkinson A; Lee DB
    Transplantation; 1995 Jul; 60(2):132-7. PubMed ID: 7624954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.